From August 20 to 22, 2026, the Annual Rhinology Congress of the Chinese Medical Association (CMA) was held in Shanghai. Organized by the CMA and its Otolaryngology-Head and Neck Surgery Society, and co-organized by the Shanghai Medical Association and the Eye & ENT Hospital of Fudan University, the event gathered over a thousand registered clinicians, featuring more than 1,000 submitted papers and extensive scientific poster presentations.
The congress covered a broad spectrum of advanced topics, including chronic rhinosinusitis, allergic rhinitis, sinonasal neoplasms, endoscopic skull base surgery, and the integration of artificial intelligence and medical-engineering cross-innovation in rhinology.
Empowering Minimally Invasive ENT & Skull Base Procedures
Xishan Medical participated with its comprehensive minimally invasive surgical solutions for otolaryngology-head and neck surgery. As Xishan’s flagship core product platform, the Surgical Power Devices provide dependable performance for diverse nasal and skull base interventions.
At the center of clinical interest were Xishan’s Next-Generation Integrated Skull Base Drill and the Patented Variable-Angle Bur:
- Integrated Skull Base Drill: Engineered with an ultra-slim profile and ergonomic balance to maximize direct visualization within narrow nasal and paranasal corridors.
- Variable-Angle Bur: Enables surgeons to adjust cutting angles flexibly within tight anatomical regions, facilitating precise bone removal without excessive retraction of adjacent soft tissues.
The Xishan booth welcomed numerous attendees and rhinology experts who engaged in hands-on equipment testing. Discussions centered around motor performance, structural ergonomics, and clinical adaptation for anterior skull base procedures.
Xishan Medical will persistently anchor its R&D around frontline clinical needs, driving the clinical translation of advanced medical equipment and delivering safer, more precise, and efficient minimally invasive solutions to clinicians worldwide.